BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21410039)

  • 21. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.
    Arnaud JP; Nordlinger B; Bosset JF; Boes GH; Sahmoud T; Schlag PM; Pene F
    Br J Surg; 1997 Mar; 84(3):352-7. PubMed ID: 9117306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients.
    Vermaas M; Nuyttens JJ; Ferenschild FT; Verhoef C; Eggermont AM; de Wilt JH
    Radiother Oncol; 2008 Jun; 87(3):357-60. PubMed ID: 18353474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer.
    Haddock MG; Miller RC; Nelson H; Pemberton JH; Dozois EJ; Alberts SR; Gunderson LL
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):143-50. PubMed ID: 20395067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Brief preoperative radiotherapy reduces local recurrences and improves survival in rectal cancer].
    Peretz T; Weshler Z; Goldberg Y; Durst AL; Freund HR
    Harefuah; 2000 Jan; 138(2):96-9, 175. PubMed ID: 10883067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The integrated radiosurgical treatment of rectal cancer].
    Lo Schiavo F; Iovino F; Lojodice F; Cimmino F; Docimo G
    Ann Ital Chir; 1999; 70(4):551-7; discussion 558. PubMed ID: 10573617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The indication and surgical results of local excision following radiotherapy for low rectal cancer.
    Han SL; Zeng QQ; Shen X; Zheng XF; Guo SC; Yan JY
    Colorectal Dis; 2010 Nov; 12(11):1094-8. PubMed ID: 19863609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of locally recurrent rectal cancer, results and prognostic factors.
    Reerink O; Mulder NH; Botke G; Sluiter WJ; Szabó BG; Plukker JT; Verschueren RC; Hospers GA
    Eur J Surg Oncol; 2004 Nov; 30(9):954-8. PubMed ID: 15498640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
    Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
    Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of laparoscopic surgery on the long-term outcomes for patients with rectal cancer.
    Kim JG; Heo YJ; Son GM; Lee YS; Lee IK; Suh YJ; Cho HM; Chun CS
    ANZ J Surg; 2009 Nov; 79(11):817-23. PubMed ID: 20078533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in oropharyngeal cancer--analysis of 627 cases receiving definitive radiotherapy.
    Agarwal JP; Mallick I; Bhutani R; Ghosh-Laskar S; Gupta T; Budrukkar A; Murthy V; Sengar M; Dinshaw KA
    Acta Oncol; 2009; 48(7):1026-33. PubMed ID: 19363712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
    Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
    Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Salvage radiotherapy in postoperative recurrences of rectal and rectosigmoid carcinomas].
    Gardani G; Valvo F; Lozza L; Tana S; Zucali R
    Radiol Med; 1991 Dec; 82(6):833-8. PubMed ID: 1788440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.